Viewing Study NCT01370135


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-01-01 @ 2:47 PM
Study NCT ID: NCT01370135
Status: COMPLETED
Last Update Posted: 2013-01-16
First Post: 2011-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
Sponsor: University of Luebeck
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neovascular Glaucoma View
None Rubeosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neovascular glaucoma View
None rubeosis View
None anterior chamber View
None intraocular View
None intravitreal injections View
None Lucentis View
None Ranibizumab View
None short ans longterm effects View
None best corrected visual acuity View
None gonioscopy View
None BCVA View
None quality of life View